Equities

Faron Pharmaceuticals Oy

FARN:LSE

Faron Pharmaceuticals Oy

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)147.20
  • Today's Change-2.80 / -1.87%
  • Shares traded6.93k
  • 1 Year change-53.42%
  • Beta-0.3941
Data delayed at least 20 minutes, as of May 03 2024 10:51 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in EURView more

In 2023, Faron Pharmaceuticals Oy did not generate a significant amount of cash. Cash Flow from Financing totalled 23.98m or -- of revenues. In addition the company used 23.81m for operations while cash used for investing totalled 123.00k.
Cash flow per share-0.4026
Price/Cash flow per share--
Book value per share-0.1886
Tangible book value per share-0.2022
More ▼

Balance sheet in EURView more

Faron Pharmaceuticals Oy uses little or no debt in its capital structure.
Current ratio0.5907
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.